DCTH DELCATH SYSTEMS, INC.

8-K Current Report

Filed: March 3, 2026

Health Care

Surgical & Medical Instruments & Apparatus

DELCATH SYSTEMS, INC. (DCTH) 8-K current report filed with SEC EDGAR on March 3, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 8.01: Other Events

AI Filing Analysis
8-K

Item 8.01 · Other Events

• CHOPIN trial results published in Lancet Oncology, a high-impact peer-reviewed journal — significant clinical validation for Delcath's hepatic delivery platform
• Publication in Lancet Oncology typically boosts commercial credibility with oncologists and supports broader adoption of HEPZATO KIT

+1 more insights

Other DELCATH SYSTEMS, INC. 8-K Filings

8-K Feb 26, 2026

Get deeper insights on DELCATH SYSTEMS, INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.